Pliaglis Cream 30g

35,00 €

Pliaglis® is a prescription topical anesthetic cream containing a fixed combination of lidocaine and tetracaine (7% / 7%). It is manufactured for dermatological procedures requiring temporary local skin numbing, especially in aesthetic medicine.

Pliaglis Cream 30g – Product Description, Features, and Uses

Introduction

Pliaglis Cream 30g is a topical local anaesthetic cream containing lidocaine and tetracaine. It is designed to provide temporary numbing of the skin for certain procedures, according to its approved prescribing information. The 30g presentation offers a specified quantity for professional use, subject to confirmation of the packaging and product authorization in your market.

Key Features of Pliaglis Cream 30g

Pliaglis is formulated with two local anaesthetic ingredients that work by temporarily reducing the transmission of pain signals from nerves in the treated area. Its use may be considered in selected clinical or aesthetic settings when appropriate for the procedure and permitted by the product’s instructions.

Key features include:

  • Dual local anaesthetic formulation: Contains lidocaine and tetracaine.
  • Topical application: Designed for application to the skin as directed in the official product information.
  • Temporary skin numbing: Helps reduce sensation in the treated area for approved procedures.
  • 30g presentation: Provides a defined product quantity for handling and treatment planning.
  • Professional guidance: Requires careful adherence to the prescribing information and applicable regulations.

Applications and Important Considerations

Pliaglis Cream may be used to provide topical anaesthesia for certain procedures when indicated by the official prescribing information. Whether it is suitable for a particular aesthetic or medical procedure depends on the procedure, the patient’s circumstances, and local product authorization.

This product should not be applied casually or used outside the approved instructions. The amount applied, application duration, treated surface area, and whether the cream must be removed before a procedure are important safety considerations. Excessive application, use on inappropriate areas, or prolonged exposure can increase the risk of systemic absorption and serious adverse effects.

A healthcare professional should review allergies, medical history, potential interactions, and contraindications before use. Avoid contact with eyes, mouth, and other mucous membranes unless specifically directed by the official instructions.

Storage and Handling

Store Pliaglis Cream 30g according to the package instructions. Check the expiry date, packaging integrity, batch details, and product authenticity before use. Keep it out of children’s reach and follow the official disposal instructions.

Brand

Pliaglis

Package Content

1 tube x 30g per pack

Import

This product is from the European Community (EC)

CE-mark

This product is regulated as a medicinal product and does not carry a CE-mark

Reviews

There are no reviews yet.

Be the first to review “Pliaglis Cream 30g”

Your email address will not be published. Required fields are marked *